Tom 15, Nr 3 (2022)
Wytyczne / stanowisko ekspertów
Opublikowany online: 2022-09-28
Wyświetlenia strony
1798
Wyświetlenia/pobrania artykułu
7869
Trombofilie wrodzone — charakterystyka, diagnostyka i postępowanie u dorosłych. Zalecenia Grupy ds. Hemostazy Polskiego Towarzystwa Hematologów i Transfuzjologów — 2022
Journal of Transfusion Medicine 2022;15(3):183-195.
Streszczenie
Brak
Słowa kluczowe: wrodzona trombofiliabadanie genetycznedoustna antykoagulacjażylna choroba zakrzepowo-zatorowa
Referencje
- Middeldorp S. Inherited thrombophilia: a double-edged sword. Hematology Am Soc Hematol Educ Program. 2016; 2016(1): 1–9.
- American College of Obstetricians and Gynecologists' Committee on Practice Bulletins–Obstetrics. ACOG Practice Bulletin No. 197: Inherited Thrombophilias in Pregnancy. Obstet Gynecol. 2018; 132(1): e18–e34.
- Arachchillage DRJ, Makris M. Inherited Thrombophilia and Pregnancy Complications: Should We Test? Semin Thromb Hemost. 2019; 45(1): 50–60.
- De Stefano V, Rossi E. Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups. Thromb Haemost. 2013; 110(4): 697–705.
- Romiti GF, Corica B, Borgi M, et al. Inherited and acquired thrombophilia in adults with retinal vascular occlusion: A systematic review and meta-analysis. J Thromb Haemost. 2020; 18(12): 3249–3266.
- Bleker SM, Coppens M, Middeldorp S. Sex, thrombosis and inherited thrombophilia. Blood Rev. 2014; 28(3): 123–133.
- Mannucci PM, Franchini M. Classic thrombophilic gene variants. Thromb Haemost. 2015; 114(5): 885–889.
- Martinelli I, Stefano VDe, Mannucci P. Inherited risk factors for venous thromboembolism. Nature Reviews Cardiology. 2014; 11(3): 140–156.
- Moran J, Bauer KA. Managing thromboembolic risk in patients with hereditary and acquired thrombophilias. Blood. 2020; 135(5): 344–350.
- Salehi Omran S, Hartman A, Zakai NA, et al. Thrombophilia Testing After Ischemic Stroke: Why, When, and What? Stroke. 2021; 52(5): 1874–1884.
- Darlow J, Mould H. Thrombophilia testing in the era of direct oral anticoagulants. Clin Med (Lond). 2021; 21(5): e487–e491.
- Bertoletti L, Benhamou Y, Béjot Y, et al. Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review. Blood Rev. 2018; 32(4): 272–279.
- Stevens SM, Woller SC, Bauer KA, et al. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis. 2016; 41(1): 154–164.
- Campello E, Spiezia L, Simioni P. Diagnosis and management offactor V Leiden. Expert Rev Hematol. 2016; 9(12): 1139–1149.
- Pritchard AM, Hendrix PW, Paidas MJ. Hereditary Thrombophilia and Recurrent Pregnancy Loss. Clin Obstet Gynecol. 2016; 59(3): 487–497.
- Colucci G, Tsakiris DA. Thrombophilia screening revisited: an issue of personalized medicine. J Thromb Thrombolysis. 2020; 49(4): 618–629.
- Alameddine R, Nassabein R, Le Gal G, et al. Diagnosis and management of congenital thrombophilia in the era of direct oral anticoagulants. Thromb Res. 2020; 185: 72–77.
- Keeney S., Hasson F., McKenna H.: The Delphi technique in nursing and health research. Ames, IO, Wiley-Blackwell, 2011.
